These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 32737697)

  • 21. Can axillary lymph node dissection be omitted in patients with breast cancer and positive sentinel nodes?
    Dominici L; Golshan M
    Minerva Chir; 2010 Oct; 65(5):547-54. PubMed ID: 21081866
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of the axilla in women with breast cancer: current clinical practice and a new selective targeted approach.
    Samphao S; Eremin JM; El-Sheemy M; Eremin O
    Ann Surg Oncol; 2008 May; 15(5):1282-96. PubMed ID: 18330650
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The evolution of the sentinel node procedure in the treatment of breast cancer.
    Tvedskov TF
    Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975889
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Can radiotherapy replace axillary dissection for patients with positive sentinel nodes?
    Recht A
    Breast Dis; 2010; 31(2):91-7. PubMed ID: 21368371
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ASO Author Reflections: Sentinel Lymph Node Removal After Neoadjuvant Chemotherapy in Clinically Node-Negative Patients Can Stop After Removal of Three Lymph Nodes.
    Murphy BL; Boughey JC
    Ann Surg Oncol; 2020 Dec; 27(Suppl 3):848-849. PubMed ID: 32696307
    [No Abstract]   [Full Text] [Related]  

  • 26. Breast cancer: can axillary lymph node dissection be avoided?
    Barry M; Kell MR
    Eur J Surg Oncol; 2012 Jan; 38(1):6-7. PubMed ID: 22014429
    [No Abstract]   [Full Text] [Related]  

  • 27. Initial experience with sentinel node biopsy in breast cancer at the National Cancer Center Hospital East.
    Imoto S; Hasebe T
    Jpn J Clin Oncol; 1999 Jan; 29(1):11-5. PubMed ID: 10073145
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes.
    Veronesi U; Paganelli G; Galimberti V; Viale G; Zurrida S; Bedoni M; Costa A; de Cicco C; Geraghty JG; Luini A; Sacchini V; Veronesi P
    Lancet; 1997 Jun; 349(9069):1864-7. PubMed ID: 9217757
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ASO Author Reflections: Sentinel Lymph Node Surgery After Neoadjuvant Chemotherapy for Node-Positive Breast Cancer: Is It Oncologically Safe?
    Piltin MA; Boughey JC
    Ann Surg Oncol; 2020 Dec; 27(Suppl 3):707-708. PubMed ID: 32737696
    [No Abstract]   [Full Text] [Related]  

  • 30. Management of axillary disease.
    Caudle AS; Cupp JA; Kuerer HM
    Surg Oncol Clin N Am; 2014 Jul; 23(3):473-86. PubMed ID: 24882346
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pilot study comparing the accuracy of lymphoscintigraphy sentinel lymph node localisation with axillary node dissection in women with operable breast cancer.
    Allen B; Campbell I; Desai S; Dray M; Scarlet J
    N Z Med J; 2001 May; 114(1132):233-6. PubMed ID: 11453361
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparing Observation, Axillary Radiotherapy, and Completion Axillary Lymph Node Dissection for Management of Axilla in Breast Cancer in Patients with Positive Sentinel Nodes: A Systematic Review.
    Castelo M; Hu SY; Dossa F; Acuna SA; Scheer AS
    Ann Surg Oncol; 2020 Aug; 27(8):2664-2676. PubMed ID: 32020394
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quality of life after sentinel lymph node biopsy versus complete axillary lymph node dissection in early breast cancer: a 3-year follow-up study.
    Boguševičius A; Čepulienė D
    Medicina (Kaunas); 2013; 49(3):111-7. PubMed ID: 23893054
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patients with breast cancer and negative sentinel lymph node biopsy without additional axillary lymph node dissection: a follow-up study of up to 5 years.
    Domènech A; Benitez A; Bajén MT; Pla MJ; Gil M; Martín-Comín J
    Oncology; 2007; 72(1-2):27-32. PubMed ID: 17998787
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ASO Author Reflections: MicroRNA-Based Nomogram for Prediction of Sentinel Lymph Node Metastasis in ER+/HER2- Breast Cancer in Hoping for a Possible Omission of Sentinel Lymph Node Biopsy.
    Okuno J; Miyake T; Shimazu K; Noguchi S
    Ann Surg Oncol; 2020 Dec; 27(Suppl 3):810-811. PubMed ID: 32632881
    [No Abstract]   [Full Text] [Related]  

  • 36. ASO Author Reflections: Future View: A Recent Scientific Contribution Towards a Staging Revision of Contralateral Axillary Lymph Node Metastases from Breast Cancer.
    Magnoni F; Intra M
    Ann Surg Oncol; 2020 Oct; 27(11):4500-4501. PubMed ID: 32430751
    [No Abstract]   [Full Text] [Related]  

  • 37. [Is it possible to avoid axillary dissection?].
    Gatěk J; Vrána D; Dudešek B; Duben J
    Rozhl Chir; 2017; 96(8):318-323. PubMed ID: 29058920
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of the axilla after neoadjuvant chemotherapy for clinically node positive breast cancer: A nationwide survey study in The Netherlands.
    Vugts G; Maaskant-Braat AJ; de Roos WK; Voogd AC; Nieuwenhuijzen GA
    Eur J Surg Oncol; 2016 Jul; 42(7):956-64. PubMed ID: 27107791
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
    Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A
    Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparison of rates of lymph node metastases between patients undergoing sentinel and axillary lymphadenectomy.
    Moonka R; Hunter JA; Cray WK; Duncan M; Wechter DG
    Am J Surg; 2002 May; 183(5):558-61. PubMed ID: 12034393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.